Softgel Capsules Industry Overview
The global softgel capsules market size was valued at USD 7.62 billion in 2021 and is projected to expand at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030.
Ease of swallowing, odor and taste masking, improved absorption, enhanced bioavailability, and high atmospheric stability are some of the advantages of softgel capsules. Advancements in manufacturing technology and the introduction of new materials have added more features to the traditional capsules such as controlled drug release, tamper-evident, and formulation choice of potent APIS due to reduced degradation in stomach pH, appealing aesthetics, and longer shelf life.
Gather more insights about the market drivers, restrains and growth of the Global Softgel Capsules Market
In recent times, softgel manufacturers are focusing on developing non-gelatin-based capsules using plant-based polymers. Starch, HPMC, and gums such as Pullulan. Gelatin-free capsules satisfy the medicinal needs of vegetarians. Technical benefits for manufacturers and suppliers, and reduced animal stock waste is the leading advantage of non-gelatin-based capsules. Additionally, vegetable capsule launched by the companies like Aenova, increased their sales revenue by a double-digit percentage. Eurocaps is developing a chewable softgel capsule that provides improved taste masking capacity. Other market leaders like Catalent and Roquette are developing vegan capsules to enhance their market reach among the vegan population of the globe.
The nutraceutical industry saw a rise during this period due to improved vitamin, nutrients, and other health supplement consumption. Product launches by growing nutraceutical companies using special capsule designs, and increased adoption of vegan and vegetarian capsule options have led to the increasing demand for nutraceuticals. Adoption of a healthier lifestyle surged the vitamin capsules market demand with a demographic shift toward the geriatric population.
The market witnessed a significant boost in sales due to the pandemic. Furthermore, the rise in improved research to develop capsules for potent and critical drug molecules to overcome bioavailability issues, the development of capsules for drugs needing multi excipients like oncology medicines, and patient preference towards capsules over other oral dosage forms, are the factors influencing the market growth.
Browse through Grand View Research's Medical Devices Industry Research Reports
- Microbiome Skincare Market: Microbiome skincare products are effective against various skin conditions such as wrinkle, blemishes, and acne. A healthy microbiome skincare products protect from dryness, pathogens, and damage. Microbiome based products mainly include prebiotics, probiotics, and postbiotics.
- Ophthalmoscopes Market: Several factors such as high prevalence of ocular diseases, increasing government expenditure for eye care, and high efficiency of titanium-based instruments are expected to fuel the market growth. Strong awareness among patients regarding eye care, leads to increase in number of ophthalmic surgeries, thereby anticipated to surge the demand for ophthalmoscopes.
Key Companies Profile
Some of the prominent players operating in the global softgel capsules market include:
- Fuji Capsules Co Ltd
- Sirio Pharma
- Captek
- Patheon
- Catalent
- Eurocaps
- Aenova
- Capsugel
- Procaps Laboratories
- Soft Gel Technologies Inc.
Order a free sample PDF of Softgel Capsules Market Intelligence Study, published by Grand View Research.
